It is unclear where in the diagnostic chain this idea fits. Is it someone that already carries a diagnosis of lymphoma, but there is a question the diagnosis is wrong? Is it using lab data to make a primary diagnosis (or suggestion of diagnoses) based on a clinic visit? Are they suggesting that this data fits an ancillary role in primary diagnosis in terms of resolving subtle discrepancies between diagnoses?
Pretty much all hematopoietic malignancy diagnoses do not come from the docs you see in the clinic. They come from the docs in the back rooms with microscopes, lasers, antibodies, sequencers, and computers. Is the user of this information the person in the front whom you talk to, or the person in the back making the actual diagnosis?
Szolovits is confident that that the teamâ(TM)s model can help doctors make more accurate lymphoma diagnoses based on more comprehensive evidence â" and could even be incorporated into future WHO guidelines.
To paraphrase Yet Another Famous Movie Quote: Getting something into the WHO guidelines ain't like dusting crops, boy.